EBS
Emergent BioSolutions Inc.
EBS's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over EBS overall, supported by lower modeled downside and stronger fundamentals.
EBS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Strong | |
| Weak |
EBS's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
EBS PE Valuation
EBS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 16x next year's earnings.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
EBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
EBS has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
EBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.38 | — |
| Q3 2026 | -$5.01 | -450% |
| Q2 2026 | -$3.46 | -234% |
| Q1 2026 | -$0.19 | +$2.39 |
| Q4 2025 | $0.93 | +$4.53 |
| Q3 2025 | $1.43 | +$5.48 |
| Q2 2025 | $2.58 | +$13.77 |
| Q1 2025 | -$2.58 | +$8.38 |
| Q4 2024 | -$3.60 | +$11.18 |
EBS has swung to a loss: it lost $5.01 per share over the past year, after a profit the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over EBS on earnings quality, reporting a profit while its opponent remains loss making.
EBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $110M | -52% |
| Q2 2026 | $234.3M | +66% |
| Q1 2026 | $156.1M | -30% |
| Q4 2025 | $148.7M | -24% |
| Q3 2025 | $231.1M | -21% |
| Q2 2025 | $140.9M | -45% |
| Q1 2025 | $222.2M | -26% |
| Q4 2024 | $194.7M | -30% |
EBS's revenue has slid since its 2021 peak: $110M last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -34% | -67 points |
| Q2 2026 | -53% | -55 points |
| Q1 2026 | 6.7% | -16 points |
| Q4 2025 | -19% | -14 points |
| Q3 2025 | 33% | +11 points |
| Q2 2025 | 1.1% | +81 points |
| Q1 2025 | 22% | +9.2 points |
| Q4 2024 | -4.9% | +11 points |
EBS's operating margin was −34% last quarter, down 67 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over EBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over EBS on profitability, with a higher operating margin.
EBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $96.8M | +$102.5M |
| Q2 2026 | $54M | -48% |
| Q1 2026 | -$36.2M | -$21.4M |
| Q4 2025 | $73.8M | +$155.4M |
| Q3 2025 | -$5.7M | -104% |
| Q2 2025 | $103.5M | +141% |
| Q1 2025 | -$14.8M | +$58.6M |
| Q4 2024 | -$81.6M | -494% |
EBS still generates free cash flow, though less than at its 2021 peak: $188M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over EBS on cash flow, with more consistent year-over-year improvement.
EBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -300K shares |
| 1 year | -9.2% | -5.2M shares |
| 3 years | -1% | -500K shares |
| 5 years | -4.5% | -2.4M shares |
| Available history | -2.1% | -1.1M shares |
EBS has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100,000 |
| Q2 2026 | $9M |
| Q1 2026 | $9M |
| Q4 2025 | $9.1M |
| Q3 2025 | $8.9M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
EBS spent $27M buying back its own shares over the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
EBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 15.6x | High |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 67.1x | High |
| Q4 2024 | 5,642.0x | High |
| Q3 2021 | 1.1x | Healthy |
EBS's net debt is about 16 years of its operating earnings (EBITDA), up from 1.9 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over EBS on leverage, with a lower net debt burden relative to earnings.
EBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.0 | Neutral |
| Stochastic | 56.9 | Neutral |
EBS's weekly RSI is 42 (neutral) and its Stochastic is 57 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
EBS PE vs Healthcare Sector
| Metric | EBS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
EBS has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
EBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.44 | 8.5% below |
| 20 week MA | $6.48 | 9.1% below |
| 50 week MA | $8.41 | 30% below |
| 100 week MA | $8.14 | 28% below |
| 200 week MA | $7.37 | 20% below |
EBS is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over EBS on trend strength, trading above more of its moving averages.
EBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $93.8 | +74% |
| 2021 | $93.8 | $45.5 | -51% |
| 2022 | $45.5 | $11.0 | -76% |
| 2023 | $11.0 | $2.40 | -78% |
| 2024 | $2.40 | $8.27 | +245% |
| 2025 | $8.27 | $12.4 | +50% |
| 2026 YTD | $12.4 | $5.89 | -53% |
EBS's yearly returns have swung widely, from +245% in 2024 to −78% in 2023. It's down 53% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over EBS on returns for 2026, with the stronger performance.